BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
2.040
-0.130 (-5.99%)
At close: Nov 6, 2026, 4:00 PM EST
2.080
+0.040 (1.96%)
After-hours: Nov 6, 2026, 7:48 PM EST
BridgeBio Oncology Therapeutics Employees
BridgeBio Oncology Therapeutics had 88 employees as of June 30, 2026. The number of employees increased by 26 or 41.94% compared to the same quarter last year. That makes BridgeBio Oncology Therapeutics the 32,195th largest employer in the world and 4,161st in the United States.
Employees
88
Change (1Y)
26
Growth (1Y)
41.94%
Revenue / Employee
n/a
Profits / Employee
-$2,069,477
Market Cap
163.56M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 88 | 26 | 41.94% |
| Mar 31, 2026 | 106 | 44 | 70.97% |
| Dec 31, 2025 | 92 | 30 | 48.39% |
| Sep 30, 2025 | 81 | 19 | 30.65% |
| Mar 31, 2025 | 62 | - | - |
| Dec 31, 2024 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Entrada Therapeutics | 152 |
| Sutro Biopharma | 128 |
| Invivyd | 122 |
| Zentalis Pharmaceuticals | 106 |
| Upstream Bio | 75 |
| PepGen | 57 |
| ALX Oncology Holdings | 48 |
| Satellos Bioscience | 21 |
BBOT News
- 17 days ago - BridgeBio Oncology price target lowered to $13 from $18 at Morgan Stanley - TheFly
- 18 days ago - BridgeBio Oncology price target lowered to $16 from $22 at Oppenheimer - TheFly
- 26 days ago - BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - BridgeBio Oncology Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 1 month ago - JPMorgan cuts BridgeBio target, sees buying opportunity on selloff - TheFly
- 1 month ago - BridgeBio Oncology price target lowered to $27 from $39 at Leerink - TheFly
- 1 month ago - BridgeBio Oncology price target lowered to $22 from $24 at Raymond James - TheFly
- 1 month ago - BridgeBio Oncology price target lowered to $15 from $23 at Stifel - TheFly